Pilot--Keratinocyte specific expression system for transgene expression
$0P30FY2002ARNIH
University Of Texas Sw Med Ctr/Dallas, Dallas TX
Investigators
Linked publications & trials
Paper 36755096Paper 21432986Paper 20661293Paper 20236620Paper 19893004Paper 19321153Paper 18404279Paper 15888200Paper 15753096Paper 12270937Paper 11783936Paper 11410588Paper 11401669Paper 11238663Paper 11161566Paper 11119545Paper 11042212Paper 11035039Paper 10854067Paper 10845775Paper 10835429Paper 10655550Paper 10652290
Abstract
I propose to develop a highly efficient system for expression of proteins in the keratinocytes of skin. Such system will have two important uses. One is to tolerize the host against a particular antigen. We have recently shown that restricting antigen expression to the keratinocytes in vivo decreases the immune response to subsequent exposure to the same antigen. Improving the expression system should allow extension of this concept to allergy and autoimmunity. The second is that such a system could be used for gene therapy of skin disorders.
View original record on NIH RePORTER →